Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
Rashmi Mehta,1 Dennis Kelleher,1 Andrew Preece,2 Stephen Hughes,3 Glenn Crater4 1Respiratory Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC, USA; 2Respiratory Medicines Development Center, GlaxoSmithKline, Stockley Park West, UK; 3GlaxoSmithKline R&D, Bioanalytical Sci...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2013-03-01
|
| Series: | International Journal of COPD |
| Acceso en liña: | http://www.dovepress.com/effect-of-verapamil-on-systemic-exposure-and-safety-of-umeclidinium-an-a12593 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|